XOMA Royalty Corp. (XOMA) Stock Forecast
Data as of Aug 1, 2026Healthcare · Current price $40.17 (—)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Dec 11, 2025 | Joseph Pantginis | H.C. Wainwright | $97.00 | +141.5% |
| Dec 11, 2025 | David Risinger | Leerink Partners | $45.00 | +12.0% |
Top Analysts Covering XOMA
XOMA vs Sector & Market
| Metric | XOMA | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.33 | 2.25 | 2.42 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | +10.8% | +16316.2% | +17.1% |
| P/E Ratio | 26.18 | 2.99 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $15M | $18M | $21M | 1 |
| 2026-12-31 | $17M | $20M | $23M | 2 |
| 2027-12-31 | $49M | $61M | $79M | 2 |
| 2028-12-31 | $66M | $81M | $106M | 3 |
| 2029-12-31 | $78M | $97M | $127M | 2 |
| 2030-12-31 | $97M | $121M | $157M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $0.31 | $0.38 | $0.45 | 1 |
| 2026-12-31 | $0.38 | $0.47 | $0.55 | 1 |
| 2027-12-31 | $-0.05 | $0.69 | $1.41 | 2 |
| 2028-12-31 | $0.45 | $1.80 | $3.15 | 2 |
| 2029-12-31 | $1.90 | $2.54 | $3.55 | 1 |
| 2030-12-31 | $2.29 | $3.06 | $4.28 | 1 |
Frequently Asked Questions
What is the analyst consensus for XOMA?
The consensus among 3 analysts covering XOMA Royalty Corp. (XOMA) is Buy with an average price target of $53.75.
What is the highest price target for XOMA?
The highest price target for XOMA is $97.00, set by Joseph Pantginis at H.C. Wainwright on 2025-12-11.
What is the lowest price target for XOMA?
The lowest price target for XOMA is $45.00, set by David Risinger at Leerink Partners on 2025-12-11.
How many analysts cover XOMA?
3 analysts have issued ratings for XOMA Royalty Corp. in the past 12 months.
Is XOMA a buy or sell right now?
Based on 3 analyst ratings, XOMA has a consensus rating of Buy (2.33/5) with a +10.8% upside to the consensus target of $53.75.
What are the earnings estimates for XOMA?
Analysts estimate XOMA will report EPS of $0.38 for the period ending 2026-09-30, with revenue estimated at $18M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.